Reasoning Backwards at the George C. Marshall Institute
Submitted by Bob Burton on
In September 2001, the George C. Marshall Institute, a Washington D.C. think tank, appointed Matthew B. Crawford as its Executive Director.
No
Main Source:
Topics:
Science
Another Bone to Pick with Merck
Submitted by Diane Farsetta on
The pharmaceutical company Merck "paid an undisclosed sum to Elsevier to produce several volumes of a publication that had the look of a peer-reviewed medical journal, but contained only reprinted or summarized articles -- most of which presented data favorable to Merck products." The Australasian Journal of Bone and Joint Medicine carried "ads for Fosamax, a Merck drug for osteoporosis, and Vioxx" and "appeared to act solely as market
No
Main Source:
Topics:
Climate Front Group Ignored Its Own Scientists
Submitted by Bob Burton on
An internal document (pdf) of the Global Climate Coalition (GCC) -- an industry front group that disbanded in 2002 -- reveals that when the group chose to promote doubt about the reality of global warming it was ignoring the views of its own scientif
No
Main Source:
Profiling the Global Warming Skeptics
Submitted by Bob Burton on
The core of the small global network of global warming skeptics are once more gathering at a conference organized by the Heartland Institute, a corporate and foundation funded think tank based in Chicago.
Yes
Topics:
Science Needs Permission?
Submitted by Sheldon Rampton on
"Biotechnology companies are keeping university scientists from fully researching the effectiveness and environmental impact of the industry’s genetically modified crops, according to an unusual complaint issued by a group of those scientists," reports Andrew Pollack.
No
Main Source:
The Higher Cost of Biofuels
Submitted by Judith Siers-Poisson on
A new study found that there is a higher health cost associated with corn-based biofuels than with traditional energy forms.
No
Main Source:
Topics:
Support for Whistleblowers
Submitted by Judith Siers-Poisson on
The U.S. House of Representatives voted to strengthen protections for whistleblowers, especially those that work for the Transportation Security Administration (TSA) and in other areas of national security.
No
Main Source:
Topics:
This Is Your University, on Drugs
Submitted by Diane Farsetta on
In 2002, an independent study on hormone replacement therapy was halted, because the drugs were strongly linked to an "increased risk for breast cancer, heart disease, stroke and blood clots" in women. The same year, the University of Wisconsin-Madison began offering an online course, "funded entirely by a $12 million grant from Wyeth Pharmaceuticals," that "promoted hormone therapy, touted its benefits and downplayed its risks." Wyeth makes two hormone therapy drugs, Prempro and Premarin.
No
Topics:
How Big Tobacco Deals with Adverse Research -- and Researchers
Submitted by Anne Landman on
A case study in the January issue of the American Journal of Public Health shows the extent to which the tobacco industry works to derail research -- and researchers -- that could adversely affect it.
No
Topics:
Pages
